PEG 3350 AND ELECTROLYTES Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Peg 3350 And Electrolytes, and what generic alternatives are available?
Peg 3350 And Electrolytes is a drug marketed by Novel Labs Inc and Rising and is included in three NDAs.
The generic ingredient in PEG 3350 AND ELECTROLYTES is polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous. There are four hundred and twenty-one drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PEG 3350 AND ELECTROLYTES?
- What are the global sales for PEG 3350 AND ELECTROLYTES?
- What is Average Wholesale Price for PEG 3350 AND ELECTROLYTES?
Summary for PEG 3350 AND ELECTROLYTES
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 3 |
| Finished Product Suppliers / Packagers: | 2 |
| Clinical Trials: | 445 |
| DailyMed Link: | PEG 3350 AND ELECTROLYTES at DailyMed |
Recent Clinical Trials for PEG 3350 AND ELECTROLYTES
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| French Innovative Leukemia Organisation | Phase 2 |
| Rigshospitalet, Denmark | Phase 4 |
| Aswan Heart Centre | Phase 4 |
Pharmacology for PEG 3350 AND ELECTROLYTES
| Drug Class | Osmotic Laxative Potassium Salt |
| Mechanism of Action | Osmotic Activity |
| Physiological Effect | Increased Large Intestinal Motility Inhibition Large Intestine Fluid/Electrolyte Absorption Stimulation Large Intestine Fluid/Electrolyte Secretion |
